Home › Funds › ORBIMED ADVISORS LLC › CDNA

ORBIMED ADVISORS LLC position in CDNA

CAREDX INC · Health Care

ORBIMED ADVISORS LLC reported holding 934,800 shares of CDNA (CAREDX INC) in its Q3 2026 13F filing — a position valued at US$60.8M, representing 1.24% of its reported portfolio and ranking #24 among its reported holdings. ORBIMED ADVISORS LLC first reported this position in Q3 2026.

Latest position (Q3 2026)934.80K sh
Reported value held$60.76M
Portfolio Weight1.24%
First reportedQ3 2026
Last changeNew
Updated2026-11-17

Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR

How ORBIMED ADVISORS LLC's CDNA position evolved

ORBIMED ADVISORS LLC first disclosed a stake in CDNA in Q3 2026 at 934,800 shares (US$60.8M).

Quarter by quarter

QuarterSharesValueChange
Q3 2026 934.80K $60.76M New

About CDNA and 13F data

CDNA (CAREDX INC) is a Health Care company. 51 other funds we track also report a position in CDNA — the largest reported positions include Blue Water Life Science Advisors, LP (US$113.1M), ARK Invest (US$104.6M), Divisadero Street Capital Management, LP (US$92.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding CDNA

All CDNA fund holders →

FAQ

How long has ORBIMED ADVISORS LLC held CDNA?

ORBIMED ADVISORS LLC has disclosed CDNA holdings in 1 of the last 1 reported quarters, going back to Q3 2026.

What is ORBIMED ADVISORS LLC's current position in CDNA?

As of Q3 2026, ORBIMED ADVISORS LLC holds 934.80K shares of CDNA (CAREDX INC), valued at $60.76M, representing 1.24% of its reported portfolio and ranking #24.

Has ORBIMED ADVISORS LLC been buying or selling CDNA?

In the latest 13F filing (Q3 2026), ORBIMED ADVISORS LLC newly opened its position in CDNA.

Which other funds hold CDNA?

Other major institutional holders of CDNA include Blue Water Life Science Advisors, LP, ARK Invest, Divisadero Street Capital Management, LP, among 51 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.